Literature DB >> 1347762

Synthetic peptides analogous to the fimbrillin sequence inhibit adherence of Porphyromonas gingivalis.

J Y Lee1, H T Sojar, G S Bedi, R J Genco.   

Abstract

Fimbriae are important in the adherence of many bacterial species to the surfaces they eventually colonize. Porphyromonas (Bacteroides) gingivalis fimbriae appear to mediate adherence to oral epithelial cells and the pellicle-coated tooth surface. The role and contribution of fimbriae in the binding of P. gingivalis to hydroxyapatite (HAP) coated with saliva as a model for the pellicle-coated tooth surface were investigated. 3H-labeled P. gingivalis or the radioiodinated purified fimbriae were incubated with 2 mg of HAP beads coated with whole human saliva (sHAP) and layered on 100% Percoll to separate unbound from sHAP-bound components. The radioactivity of the washed beads was a measure of the bound components. The binding of P. gingivalis 2561 (381) cells and that of purified fimbriae were concentration dependent and saturable at approximately 10(8) cells and 40 micrograms of fimbriae added, respectively. The addition of fimbriae inhibited binding of P. gingivalis to sHAP beads by 65%, while the 75-kDa protein, which is another major surface component of P. gingivalis 2561, did not show significant inhibition, suggesting that the fimbriae are important in adherence. Encapsulated and sparsely fimbriated P. gingivalis W50 did not bind to sHAP beads. On the basis of the predicted sequence of the fimbrillin, a structural subunit of fimbriae, a series of peptides were synthesized and used to localize the active fimbrillin domains involved in P. gingivalis adherence to sHAP beads. Peptides from the carboxyl-terminal one-third of the fimbrillin strongly inhibited P. gingivalis binding to sHAP beads. Active residues within the sequence of inhibitory peptide 226-245 (peptide containing residues 226 to 245) and peptide 293-306 were identified by using smaller fragments prepared either by trypsin cleavage of the peptide 226-245 or by synthesis of smaller segments of peptide 293-306. Hemagglutinin activity, lectinlike binding, and ionic interaction did not seem to be involved in this binding since lysine, arginine, carbohydrates, and calcium ions failed to affect the binding of P. gingivalis. The observation that poly-L-lysine, bovine serum albumin, and defatted bovine serum albumin, even at high concentrations, only partially blocked the binding of P. gingivalis indicates that hydrophobic interactions are not the major forces involved in P. gingivalis binding to sHAP beads. Protease inhibitors such as EDTA, leupeptin, pepstatin, 1,10-phenanthroline, and phenylmethylsulfonyl fluoride did not interfere with the binding of P. gingivalis. However, the binding of P. gingivalis to trypsin- or chymotrypsin-pretreated sHAP beads was reduced.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347762      PMCID: PMC257044          DOI: 10.1128/iai.60.4.1662-1670.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Synthetic peptide segments from the Escherichia coli porin OmpF constitute leukocyte activators.

Authors:  H M Vordermeier; P Hoffmann; F O Gombert; G Jung; W G Bessler
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

2.  Secondary structure and immunogenicity of hybrid synthetic peptides derived from two Plasmodium falciparum pre-erythrocytic antigens.

Authors:  J A Londoño; H Gras-Masse; C Dubeaux; A Tartar; P Druilhe
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

3.  Peptide analogs to a fibronectin receptor inhibit attachment of Staphylococcus aureus to fibronectin-containing substrates.

Authors:  R H Raja; G Raucci; M Hook
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

4.  Purification, characterization and immunolocalization of fimbrial protein from Porphyromonas (bacteroides) gingivalis.

Authors:  H T Sojar; J Y Lee; G S Bedi; M I Cho; R J Genco
Journal:  Biochem Biophys Res Commun       Date:  1991-03-15       Impact factor: 3.575

5.  Adherent interactions which may affect microbial ecology in the mouth.

Authors:  R J Gibbons
Journal:  J Dent Res       Date:  1984-03       Impact factor: 6.116

6.  Association of proteases of Porphyromonas (Bacteroides) gingivalis with its adhesion to Actinomyces viscosus.

Authors:  J Li; R P Ellen; C I Hoover; J R Felton
Journal:  J Dent Res       Date:  1991-02       Impact factor: 6.116

7.  Purification, characterization, and localization of a major membrane protein antigen from Porphyromonas (bacteroides) gingivalis.

Authors:  H T Sojar; J Y Lee; G S Bedi; M I Cho; R J Genco
Journal:  Biochem Int       Date:  1991-10

8.  API ZYM system for identification of Bacteroides spp., Capnocytophaga spp., and spirochetes of oral origin.

Authors:  B E Laughon; S A Syed; W J Loesche
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

9.  Adherence of Porphyromonas (Bacteroides) gingivalis to Streptococcus sanguis in vitro.

Authors:  M W Stinson; K Safulko; M J Levine
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  Molecular mapping of human band 3 anion transport regions using synthetic peptides.

Authors:  M M Kay
Journal:  FASEB J       Date:  1991-01       Impact factor: 5.191

View more
  41 in total

Review 1.  Microbial biofilms: from ecology to molecular genetics.

Authors:  M E Davey; G A O'toole
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Characterization of an adherence and antigenic determinant of the ArgI protease of Porphyromonas gingivalis which is present on multiple gene products.

Authors:  M A Curtis; J Aduse-Opoku; J M Slaney; M Rangarajan; V Booth; J Cridland; P Shepherd
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Potent In Vitro and In Vivo Activity of Plantibody Specific for Porphyromonas gingivalis FimA.

Authors:  Young-Suk Choi; Ji-Hoi Moon; Tae-Geum Kim; Jin-Yong Lee
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

4.  Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli.

Authors:  Tae-Geum Kim; Nguyen-Xuan Huy; Mi-Young Kim; Dong-Keun Jeong; Yong-Suk Jang; Moon-Sik Yang; William H R Langridge; Jin-Yong Lee
Journal:  Mol Biotechnol       Date:  2008-09-20       Impact factor: 2.695

5.  Role of Porphyromonas gingivalis protease activity in colonization of oral surfaces.

Authors:  M Tokuda; M Duncan; M I Cho; H K Kuramitsu
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

6.  Porphyromonas gingivalis fimbriae use beta2 integrin (CD11/CD18) on mouse peritoneal macrophages as a cellular receptor, and the CD18 beta chain plays a functional role in fimbrial signaling.

Authors:  A Takeshita; Y Murakami; Y Yamashita; M Ishida; S Fujisawa; S Kitano; S Hanazawa
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Salivary receptors for recombinant fimbrillin of Porphyromonas gingivalis.

Authors:  A Amano; H T Sojar; J Y Lee; A Sharma; M J Levine; R J Genco
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats.

Authors:  R Malek; J G Fisher; A Caleca; M Stinson; C J van Oss; J Y Lee; M I Cho; R J Genco; R T Evans; D W Dyer
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

9.  Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction.

Authors:  R T Evans; B Klausen; H T Sojar; G S Bedi; C Sfintescu; N S Ramamurthy; L M Golub; R J Genco
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

10.  Production of Monoclonal Antibodies Specific to FimA of Porphyromonas gingivalis and Their Inhibitory Activity on Bacterial Binding.

Authors:  Eun-Mi Koh; Ju Kim; Jin-Yong Lee; Tae-Geum Kim
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.